Streptococcus dysgalactiae subsp. equisimilis

Cat no. YSL-qP-EC-SDSE-100

Streptococcus dysgalactiae subsp. equisimilis

Cat no. YSL-qP-EC-SDSE-100

A complete qPCR kit for the detection of Streptococcus dysgalactiae subsp. equisimilis

S. dysgalactiae subsp. equisimilis, a bacterium that can infect both humans and horses, is associated with a range of infections such as skin and soft tissue infections, respiratory tract infections, and invasive diseases. The pathogen can cause symptoms such as fever, swelling, pain, and redness at the infection site. Early detection of this target is crucial in both human and veterinary sectors to prevent the spread of infections and administer appropriate treatment.

YouSeq's qPCR kit to detect S. dysgalactiae subsp. equisimilis allows for rapid and accurate identification of the pathogen in clinical and environmental samples. By detecting this target efficiently, potential outbreaks can be prevented, leading to improved public health and reduced economic burden associated with treating infections caused by this bacterium.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target Specific primer/probe
Endogenous control primer/probe
qPCR OneStep MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer
ROX passive reference

Technical specification


Target Gene(s):skc gene,hypothetical protein gene
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)
Target Pathogen: FAM labelled
Endogenous Control: VIC/HEX labelled

Product variants


YSL-qP-EC-SDSE-100 : Lyophilised version for ambient shipping
YS-qP-EC-SDSE-100 : Frozen version for dry ice shipping

Pseudonyms

Streptococcus dysgalactiae subsp. equisimilis; Group C Streptococcus; Streptococcus equisimilis; Group C Streptococci; Dysgalactiae equisimilis

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources